Inactive Instrument

News Hercules Technology Growth Capital Inc Nasdaq

Equities

US4270965084

Real-time Estimate Cboe BZX Other stock markets 20:28:37 28/05/2024 BST			5-day change	1st Jan Change
19.32 ^USD	0.00%		0.00%	0.00%

05-17	UBS Adjusts Price Target on Hercules Capital to $18.50 From $18, Maintains Neutral Rating	MT
05-15	Adaptimmune Therapeutics Enters Into $125 Million Term Loan Facility With Hercules Capital	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Hercules Capital : 2025 Proxy Statement	05-17	PU
UBS Adjusts Price Target on Hercules Capital to $18.50 From $18, Maintains Neutral Rating	05-17	MT
Adaptimmune Therapeutics Enters Into $125 Million Term Loan Facility With Hercules Capital	05-15	MT
Hercules Capital Announces Date of 2024 Annual Meeting of Stockholders	05-13	BU
Ex-dividend day	05-12	FA
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS	05-10	AQ
Electric Hydrogen secures $100M credit facility from HSBC, J.P. Morgan, Stifel Bank and Hercules Capital to decarbonize critical industries at scale	05-10	AQ
X4 Pharmaceuticals Receives $125 Million Additional Capital; Shares Rise	05-09	MT
Verona Pharma Signs Financing Agreements for Up to $650 Million	05-09	MT
X4 Pharmaceuticals Announces $125 Million Capital Infusion from $105 Million Sale of Priority Review Voucher and $20 Million Drawdown from Existing Loan Facility	05-09	AQ
Hercules Capital Announces Upcoming Event for the Financial Community	05-07	BU
Transcript : Hercules Capital, Inc., Q1 2024 Earnings Call, May 02, 2024	05-02
Hercules Capital: Q1 Earnings Snapshot	05-02	AQ
Hercules Capital, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-02	CI
Hercules Capital Reports First Quarter 2024 Financial Results	05-02	BU
Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the First Quarter 2024	04-30	BU
Hercules Capital, Inc. Declares First Quarter Cash Dividend, Payable on May 14, 2024	04-30	CI
Hercules Capital Signs $35 Million Loan Facility to Fund Development of Tenosynovial Giant Cell Tumour Treatment	04-30	MT
Hercules Capital Celebrates 20th Anniversary with $20.0 Billion in Cumulative Originations	04-24	BU
Hercules Capital Announces Date for Release of First Quarter 2024 Financial Results and Conference Call	04-18	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Hercules Technology Growth Capital Inc Nasdaq

Equities

US4270965084

Summary

Filters